Evidence map›Paper›PMID 23432429›Full record

ArticleChemical research in toxicology2013

Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition.

Tsutomu Shimada, Donghak Kim, Norie Murayama, Katsuhiro Tanaka, Shigeo Takenaka, Leslie D Nagy, Lindsay M Folkman, Maryam K Foroozesh, Masayuki Komori, Hiroshi Yamazaki and 1 more

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Preference forXenobiotica; the fate of foreign compounds in biological systems · 2020
    Article
  3. Article
  4. Site-specific oxidation of flavanone and flavone by cytochrome P450 2A6 in human liver microsomes.Xenobiotica; the fate of foreign compounds in biological systems · 2019
    Article
  5. Cytochrome P450 2A6 and other human P450 enzymes in the oxidation of flavone and flavanone.Xenobiotica; the fate of foreign compounds in biological systems · 2019
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13.Xenobiotica; the fate of foreign compounds in biological systems · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Tsutomu ShimadaDepartment of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine , Nashville, Tennessee 37232-0146, United States.
Donghak Kim
Norie Murayama
Katsuhiro Tanaka
Shigeo Takenaka
Leslie D Nagy
Lindsay M Folkman
Maryam K Foroozesh
Masayuki Komori
Hiroshi Yamazaki
F Peter Guengerich
Vanderbilt University · USOsaka Prefecture University · JPShowa Pharmaceutical University · JPXavier University of Louisiana · US

Funding

X RAY MODELING OF DOPAMINE AGONISTSS06GM008008 · NIGMS · XAVIER UNIVERSITY OF LOUISIANA · PI IRELAND, SHUBHA K · 1989 to 2007
$9.5M
Metabolism of Carcinogens and Drugs by Human P450sR37CA090426 · NCI · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 2006 to 2015
$3.6M
NCI NIH HHS R37 CA090426NIGMS NIH HHS S06 GM008008NIGMS NIH HHS S06 GM08008
6 · The paper itself

Abstract

A total of 68 chemicals including derivatives of naphthalene, phenanthrene, fluoranthene, pyrene, biphenyl, and flavone were examined for their abilities to interact with human P450s 2A13 and 2A6. Fifty-one of these 68 chemicals induced stronger Type I binding spectra (iron low- to high-spin state shift) with P450 2A13 than those seen with P450 2A6, i.e., the spectral binding intensities (ΔAmax/Ks ratio) determined with these chemicals were always higher for P450 2A13. In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with P450 2A13. Coumarin 7-hydroxylation, catalyzed by P450 2A13, was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values. On the basis of the intensities of the spectral changes and inhibition of P450 2A13, we classified the 68 chemicals into eight groups based on the order of affinities for these chemicals and inhibition of P450 2A13. The metabolism of chemicals by P450 2A13 during the assays explained why some of the chemicals that bound well were poor inhibitors of P450 2A13. Finally, we compared the 68 chemicals for their abilities to induce Type I spectral changes of P450 2A13 with the Reverse Type I binding spectra observed with P450 1B1: 45 chemicals interacted with both P450s 2A13 and 1B1, indicating that the two enzymes have some similarty of structural features regarding these chemicals. Molecular docking analyses suggest similarities at the active sites of these P450 enzymes. These results indicate that P450 2A13, as well as Family 1 P450 enzymes, is able to catalyze many detoxication and activation reactions with chemicals of environmental interest.

Indexed as

Aryl Hydrocarbon HydroxylasesBinding SitesCarcinogensCytochrome P-450 CYP1B1Cytochrome P-450 CYP2A6Environmental PollutantsEscherichia coliFlavonoidsHumansMolecular Docking SimulationPolycyclic Aromatic HydrocarbonsAryl Hydrocarbon HydroxylasesCarcinogensCYP1B1 protein, humanCYP2A13 protein, humanCytochrome P-450 CYP1B1Cytochrome P-450 CYP2A6Environmental PollutantsFlavonoidsPolycyclic Aromatic Hydrocarbons

Identifiers

PMID23432429
PMCPMC4026275
OpenAlexW2070944803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.